Danish biotech excels through collaboration
Close cooperation between universities, hospitals and industries has made Denmark a global leader in biotech research and innovation
Denmark is a world frontrunner in biotech research, education and innovation
Today, Denmark is a global leader in areas such as enzymes, diabetes, CNS and cancer research. In fact, “Medicon Valley” in Denmark is the third largest commercial drug development pipeline in Europe.
Collaboration key to success
A key to the success of Danish biotech is the close collaboration between universities, hospitals and companies in Denmark, known as the Danish Biotech Cluster.
"Denmark’s biotechnology cluster highlights the importance of communication between scientists in labs, researchers in industry, and clinicians in hospitals", writes PhD Rasmus Beedholm-Ebsen in the acclaimed scientific publication European Biopharmaceutical Review (EBR).